N-[[(1S,2S,6R,14R,16R)-5-(cyclopropylmethyl)-11-hydroxy-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-16-yl]methyl]-3-(2H-tetrazol-5-yl)propanamide

C28H36N6O4 — CID 91801275

IUPACN-[[(1S,2S,6R,14R,16R)-5-(cyclopropylmethyl)-11-hydroxy-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-16-yl]methyl]-3-(2H-tetrazol-5-yl)propanamide
SMILESCOC12CC[C@@]3(C[C@@H]1CNC(=O)CCc1nn[nH]n1)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5
InChIInChI=1S/C28H36N6O4/c1-37-28-9-8-26(13-18(28)14-29-22(36)7-6-21-30-32-33-31-21)20-12-17-4-5-19(35)24-23(17)27(26,25(28)38-24)10-11-34(20)15-16-2-3-16/h4-5,16,18,20,25,35H,2-3,6-15H2,1H3,(H,29,36)(H,30,31,32,33)/t18-,20-,25-,26-,27+,28?/m1/s1
InChIKeyAWINNJUIVOCERC-ZFNNNXMWSA-N
MW520.63 g/mol
LogP1.88
Rot. Bonds8

About N-[[(1S,2S,6R,14R,16R)-5-(cyclopropylmethyl)-11-hydroxy-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-16-yl]methyl]-3-(2H-tetrazol-5-yl)propanamide

N-[[(1S,2S,6R,14R,16R)-5-(cyclopropylmethyl)-11-hydroxy-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-16-yl]methyl]-3-(2H-tetrazol-5-yl)propanamide (PubChem CID 91801275) has the molecular formula C28H36N6O4 and a molecular weight of 520.63 g/mol. Its IUPAC name is N-[[(1S,2S,6R,14R,16R)-5-(cyclopropylmethyl)-11-hydroxy-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-16-yl]methyl]-3-(2H-tetrazol-5-yl)propanamide.

Molecular Properties

Compound NameN-[[(1S,2S,6R,14R,16R)-5-(cyclopropylmethyl)-11-hydroxy-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-16-yl]methyl]-3-(2H-tetrazol-5-yl)propanamide
PubChem CID91801275
Molecular FormulaC28H36N6O4
Molecular Weight520.63 g/mol
Exact Mass520.28
IUPAC NameN-[[(1S,2S,6R,14R,16R)-5-(cyclopropylmethyl)-11-hydroxy-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-16-yl]methyl]-3-(2H-tetrazol-5-yl)propanamide
SMILESCOC12CC[C@@]3(C[C@@H]1CNC(=O)CCc1nn[nH]n1)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5
InChIInChI=1S/C28H36N6O4/c1-37-28-9-8-26(13-18(28)14-29-22(36)7-6-21-30-32-33-31-21)20-12-17-4-5-19(35)24-23(17)27(26,25(28)38-24)10-11-34(20)15-16-2-3-16/h4-5,16,18,20,25,35H,2-3,6-15H2,1H3,(H,29,36)(H,30,31,32,33)/t18-,20-,25-,26-,27+,28?/m1/s1
InChIKeyAWINNJUIVOCERC-ZFNNNXMWSA-N
XLogP1.88
TPSA125.49 Ų
H-Bond Donors3
H-Bond Acceptors8
Rotatable Bonds8
Heavy Atoms38
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500520.63
LogP ≤ 51.88
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 108

Analyze N-[[(1S,2S,6R,14R,16R)-5-(cyclopropylmethyl)-11-hydroxy-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-16-yl]methyl]-3-(2H-tetrazol-5-yl)propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[[(1S,2S,6R,14R,16R)-5-(cyclopropylmethyl)-11-hydroxy-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-16-yl]methyl]-3-(2H-tetrazol-5-yl)propanamide?
The IUPAC name of N-[[(1S,2S,6R,14R,16R)-5-(cyclopropylmethyl)-11-hydroxy-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-16-yl]methyl]-3-(2H-tetrazol-5-yl)propanamide (CID 91801275) is N-[[(1S,2S,6R,14R,16R)-5-(cyclopropylmethyl)-11-hydroxy-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-16-yl]methyl]-3-(2H-tetrazol-5-yl)propanamide.
What is the SMILES notation for N-[[(1S,2S,6R,14R,16R)-5-(cyclopropylmethyl)-11-hydroxy-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-16-yl]methyl]-3-(2H-tetrazol-5-yl)propanamide?
The canonical SMILES for N-[[(1S,2S,6R,14R,16R)-5-(cyclopropylmethyl)-11-hydroxy-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-16-yl]methyl]-3-(2H-tetrazol-5-yl)propanamide is COC12CC[C@@]3(C[C@@H]1CNC(=O)CCc1nn[nH]n1)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5.
What is the InChIKey of N-[[(1S,2S,6R,14R,16R)-5-(cyclopropylmethyl)-11-hydroxy-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-16-yl]methyl]-3-(2H-tetrazol-5-yl)propanamide?
The InChIKey is AWINNJUIVOCERC-ZFNNNXMWSA-N. The full InChI is InChI=1S/C28H36N6O4/c1-37-28-9-8-26(13-18(28)14-29-22(36)7-6-21-30-32-33-31-21)20-12-17-4-5-19(35)24-23(17)27(26,25(28)38-24)10-11-34(20)15-16-2-3-16/h4-5,16,18,20,25,35H,2-3,6-15H2,1H3,(H,29,36)(H,30,31,32,33)/t18-,20-,25-,26-,27+,28?/m1/s1.
What are the key properties of N-[[(1S,2S,6R,14R,16R)-5-(cyclopropylmethyl)-11-hydroxy-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-16-yl]methyl]-3-(2H-tetrazol-5-yl)propanamide?
N-[[(1S,2S,6R,14R,16R)-5-(cyclopropylmethyl)-11-hydroxy-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-16-yl]methyl]-3-(2H-tetrazol-5-yl)propanamide has a molecular weight of 520.63 g/mol, XLogP of 1.88, 8 rotatable bonds, 3 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[(1S,2S,6R,14R,16R)-5-(cyclopropylmethyl)-11-hydroxy-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-16-yl]methyl]-3-(2H-tetrazol-5-yl)propanamide is sourced from PubChem (CID 91801275), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).